Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog
Mark Siebert

Mark Siebert

Director, Research collaborations, Elsevier

About the author: Mark is developing and managing Elsevier’s flagship partnerships in Europe and Life Sciences around e.g. Artificial Intelligence or Research integrity. Examples are the launch of Elsevier’s AI lab as part of Amsterdam Data Science or the joint innovation center with Humboldt University Berlin. He is a co-author of Elsevier’s recognized AI report. He has a research background (PhD) in Business Informatics (Semantic Search) from the University of Kaiserslautern, Germany. He holds a Technical Master in Business Administration from University of Stuttgart, Germany. He led the Public Sector business with eGovernment solutions for the IT Solution business of Siemens AG in Germany. Besides various managerial and business development roles in Siemens he set-up with his own start-up a platform for language courses during the new economy. Mark developed Elsevier’s global engagement with leading research institutions, such as Harvard, Oxford and with commercial partners in emerging markets. He has a strong personal interest in digital transformation, knowledge management, complex systems research and societal impact of science.

Posts by Mark Siebert

The Dawn of a European Health Data Space – Challenges

Posted on July 16th, 2020 in Pharma R&D

The European data strategy aims to construct common data spaces for all, create a single EU market for data, and catalyze a dynamic data economy. In a previous post, we briefly described the essence of the envisioned heath data space and pointed at opportunities and possible starting points to transform this vision into reality.


The Dawn of a European Health Data Space – Opportunities

Posted on July 9th, 2020 in Pharma R&D

At the beginning of 2020, the European Commission introduced a “European strategy for data.” The document proposes to bolster and advance the data economy in Europe with a view towards capturing “the benefits of better use of data, including greater productivity and competitive markets, but also improvements in health and well-being, environment, transparent governance and convenient public services.”


Personal Health Train initiative gives researchers data access FAIRly

Posted on March 19th, 2020 in Pharma R&D

Health data is everywhere. It is managed by universities, research centers, medical institutions and by individuals themselves. With this valuable data located in so many disparate places, and organized differently in each place, it can be difficult for researchers to access and make use of it.


Elsevier supports Amsterdam’s AI initiatives

Posted on January 29th, 2020 in Pharma R&D

Amsterdam, a vibrant and renowned cultural destination, has also been enlarging its reputation as an innovative scientific hub. A series of big new national initiatives, including the corporate Kickstart AI program and the academia-driven AI Technology for People initiative (which is making “AI for Health” one of its main priorities), have put the focus squarely on artificial intelligence.


  1. 1
  2. 2